A New Audio Interview with James Katzaroff, Chairman and Chief Executive Officer of Advanced Medical Isotope Corporation, is now at SmallCapVoice.com

AUSTIN, Texas, April 26, 2012 /PRNewswire/ -- SmallCapVoice.com, Inc. announced today that a new audio interview with Advanced Medical Isotope Corporation (OTCBB: ADMD) is now available. Advanced Medical Isotope Corporation is a U.S.-based public company engaged in the production and distribution of medical isotopes and in the development and identification of medical isotope technologies that are changing the practice of medicine and revolutionizing the standard of available medical care. The interview can be heard at http://smallcapvoice.com/blog/4-25-12-smallcapvoice-interview-with-advanced-medical-isotope-corp-otcbb-admd/.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation is a U.S.-based public company engaged in the production and distribution of medical isotopes and in the development and identification of medical isotope technologies that are changing the practice of medicine and revolutionizing the standard of available medical care. For more information, please visit our website, www.isotopeworld.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933, including, but not limited to, statements related to AMIC's beliefs and expectations regarding the licensed patents. These statements involve current expectations and beliefs as to future events and other statements that are not historical facts. Known and unknown risks and uncertainties can affect the accuracy of forward-looking statements. Factors that could affect actual future events or results include, but are not limited to, risks relating to product development, regulatory approval, sales and marketing, competition, risks relating to patents, and such other risks as are identified in AMIC's annual report on Form 10-K with the U.S. Securities and Exchange Commission. These forward-looking statements apply only as of the date of this press release, and AMIC undertakes no duty to publicly announce or report revisions to these statements as new information becomes available that may change AMIC's expectations.

Contact:
Advanced Medical Isotope Corporation
James C. Katzaroff
(509)736-4000
6208 W. Okanogan Ave.
Kennewick, Wa. 99336

Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
[email protected]

SOURCE SmallCapVoice.com